After Hours Summary: GMED +10.2% sharply higher on upside guidance; STZ +2.9% and AZZ +2% higher on earnings; APLD -0.5% ticks lower on earnings; Defense stocks strong after-hours
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: GMED +10.2% (guidance), STZ +2.9%, LENZ +2.4%, AZZ +2%
Companies trading higher in after hours in reaction to news: LMT +6.8% (President Trump wants a 50% defense budget increase, according to Bloomberg), NOC +4.6% (President Trump wants a 50% defense budget increase, according to Bloomberg), LHX +4.3% (President Trump wants a 50% defense budget increase, according to Bloomberg), GD +4.2% (President Trump wants a 50% defense budget increase, according to Bloomberg), KRMN +2.9% (agrees to acquire Seemann Composites and Materials Sciences; reaffirms FY25 guidance), RTX +2.9% (mentioned in truth social post), ANGI +2.6% (reduction in workforce), HII +2.5% (President Trump wants a 50% defense budget increase, according to Bloomberg), COST +1.4% (December comps), SMTI +1.3% (innovative technology contract from Vizient for BIASURGE Advanced Surgical Solution), BA +0.8% (President Trump wants a 50% defense budget increase, according to Bloomberg), RPM +0.7% (to acquire Kalzip GmbH), CEG +0.5% (completes acquisition of Calpine Corporation), GLUE +0.3% (stock offering), XOM +0.2% (provides impacts to Q4 planned and seasonal factors and other items)
After Hours Losers
Companies trading lower in after hours in reaction to earnings/guidance: PHAT -11.8% (guidance; also mixed shelf offering; also stock offering by selling shareholders), FC -10.2%, KRUS -3%, JEF -2.9%, PSMT -2.4%, ABBV -0.6% (guidance), APLD -0.5%
Companies trading lower in after hours in reaction to news: IMRX -20.9% (updated overall survival and safety data from its ongoing Phase 2a trial of atebimetinib), PHAT -11.8%, RVMD -10.2% (lower after AbbVie (ABBV) says it's not in talks to purchase RVMD, according to Bloomberg), CSIQ -7.7% (convertible notes offering), CBIO -1.4% (stock offering by selling shareholders), PR -0.6% (completes corporate reorginzation; also mixed shelf offering), ABVX -0.4% (2026 corporate outlook), LLY -0.1% (confirms agreement to acquire VTYX)